Low-risk prostate cancer is treated aggressively

A recent report has shown too many men with low-risk prostate cancers, those whose level of prostate-specific antigen (PSA) is normal or below normal, still receive aggressive treatment.

Recent evidence has shown that among older men with low-risk prostate cancer, it’s not the cancer they die from, but another condition. For these men, watchful waiting is probably better than surgery or radiation therapy, the researchers noted.

The report is published in the July 26 issue of the Archives of Internal Medicine.